MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,649 | -49.5% | 518 | -20.2% | 0.01% | -42.1% |
Q2 2023 | $149,919 | -62.0% | 649 | -60.2% | 0.02% | -64.8% |
Q1 2023 | $394,642 | -29.5% | 1,629 | -15.6% | 0.05% | -32.5% |
Q4 2022 | $559,892 | +347.9% | 1,929 | 0.0% | 0.08% | +281.0% |
Q3 2022 | $125,000 | -26.5% | 1,929 | +10.5% | 0.02% | -27.6% |
Q2 2022 | $170,000 | -9.6% | 1,746 | -8.9% | 0.03% | 0.0% |
Q1 2022 | $188,000 | -6.0% | 1,917 | -18.7% | 0.03% | -3.3% |
Q4 2021 | $200,000 | +46.0% | 2,358 | +37.2% | 0.03% | +30.4% |
Q3 2021 | $137,000 | -19.4% | 1,719 | -1.5% | 0.02% | -20.7% |
Q2 2021 | $170,000 | +7.6% | 1,746 | +29.1% | 0.03% | +3.6% |
Q1 2021 | $158,000 | +113.5% | 1,352 | +102.7% | 0.03% | +100.0% |
Q4 2020 | $74,000 | +42.3% | 667 | +53.3% | 0.01% | +27.3% |
Q3 2020 | $52,000 | +100.0% | 435 | +90.0% | 0.01% | +83.3% |
Q2 2020 | $26,000 | – | 229 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |